See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069530_2018_Filana_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001069530, Filana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,663,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 156,000 |
| 3 | remainder_Assets | 12,000 |
| 4 | LiabilitiesCurrent | 1,132,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,322,009 |
| 9 | ResearchAndDevelopmentExpense | 7,717,613 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 60,370 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,831,000 |
| 1 | Liabilities | 1,132,000 |
| 2 | Expenses | 12,039,622 |
| 3 | Revenues | 60,370 |
| 4 | StockholdersEquity | 9,699,000 |
| 5 | NetIncome | -11,979,252 |
| 6 | ComprehensiveNetIncome | -11,979,252 |
| 7 | BaseVar | 12,031,496 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.53 |
| 9 | EconomicCapitalRatio | 2.70 |